As of December, 2023, an estimated 77% of people with HIV worldwide were receiving ART, with more than 80% of these individuals being treated with tenofovir, lamivudine, and dolutegravir. This ...

bInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa cDepartment of Medicine, University of Cape Town, Cape Town, South Africa dBlizard Institute, ...

Evidence Rating Level: 1 (Excellent) Study Rundown: The mainstay of treatment for HIV in both children and adults is antiretroviral therapy (ART). Access to HIV care is improving on a global scale, ...